Physician

Wajdi Al Shweiat

According to 2025 Medicare claims, Wajdi Shweiat (NPI: 1023493574) practices nephrology in the Niles, MI market, with the plurality of this provider's patient population coming from Berrien, MI. This provider's primary affiliated billing organization is LAKE MICHIGAN NEPHROLOGY, L.L.C (NPI: 1821201500; TIN: 383572004) and primary practice location at 49085-8511. Shweiat is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Shweiat's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 322 traditional Medicare patients, billed 1,449 HCPCS/CPT codes, and received $128,094 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,100 prescription claims across 415 beneficiaries totaling $581,134 in drug costs, led by Jardiance (Empagliflozin). DME data shows 41 claims. Open Payments data shows 6 records totaling $126,168. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $351 to $581,134. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	129	457	$34,049
2021	332	1,273	$162,549
2022	332	1,266	$160,165
2023	314	1,185	$145,494
2024	322	1,449	$128,094

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	12	35	$351
2016	53	330	$9,702
2017	34	253	$10,592
2018	41	202	$16,337
2019	28	109	$7,036
2020	55	168	$8,197
2021	156	550	$28,019
2022	246	918	$53,848
2023	293	1,322	$139,349
2024	415	2,100	$581,134

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	11	$3,004
2022	N/R	N/R	N/R
2023	N/R	50	$738
2024	N/R	41	$621

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	63	149	$271
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	30	30	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	171	458	$91
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	68	144	$64
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	171	452	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	206	13,020	$248,794
Farxiga	Dapagliflozin Propanediol	88	5,610	$101,885
Kerendia	Finerenone	66	4,780	$100,442
Lokelma	Sodium Zirconium Cyclosilicate	38	2,273	$52,293
Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	35	1,809	$5,107

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	19	$226
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	11	$207
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	11	$188

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$59	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$126,109	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Wajdi Al Shweiat?

Tedicare shows public-source Medicare data for Wajdi Al Shweiat (NPI 1023493574), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wajdi Al Shweiat have ACO affiliation data?

Wajdi Al Shweiat is shown with ACO affiliation data for West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to Wajdi Al Shweiat?

Wajdi Al Shweiat is linked to LAKE MICHIGAN NEPHROLOGY, L.L.C (billing NPI 1821201500) in the available physician profile data.

Does Wajdi Al Shweiat have Open Payments data?

Wajdi Al Shweiat has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.